HK1032354A1 - Gastroprotected omerprazole microgranules, method for obtaining same and pharmaceutical preparations - Google Patents

Gastroprotected omerprazole microgranules, method for obtaining same and pharmaceutical preparations

Info

Publication number
HK1032354A1
HK1032354A1 HK01102965A HK01102965A HK1032354A1 HK 1032354 A1 HK1032354 A1 HK 1032354A1 HK 01102965 A HK01102965 A HK 01102965A HK 01102965 A HK01102965 A HK 01102965A HK 1032354 A1 HK1032354 A1 HK 1032354A1
Authority
HK
Hong Kong
Prior art keywords
microgranules
omerprazole
gastroprotected
pharmaceutical preparations
obtaining same
Prior art date
Application number
HK01102965A
Other languages
English (en)
Inventor
Patrice Debregeas
Gerard Leduc
Pascal Oury
Pascal Suplie
Original Assignee
Ethypharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9522415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1032354(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ethypharm Sa filed Critical Ethypharm Sa
Publication of HK1032354A1 publication Critical patent/HK1032354A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK01102965A 1998-01-30 2001-04-25 Gastroprotected omerprazole microgranules, method for obtaining same and pharmaceutical preparations HK1032354A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9801098A FR2774288B1 (fr) 1998-01-30 1998-01-30 Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques
PCT/FR1998/001783 WO1999038511A1 (fr) 1998-01-30 1998-08-10 Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques

Publications (1)

Publication Number Publication Date
HK1032354A1 true HK1032354A1 (en) 2001-07-20

Family

ID=9522415

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01102965A HK1032354A1 (en) 1998-01-30 2001-04-25 Gastroprotected omerprazole microgranules, method for obtaining same and pharmaceutical preparations

Country Status (32)

Country Link
US (1) US6551621B1 (xx)
EP (1) EP1051174B2 (xx)
JP (1) JP4286452B2 (xx)
KR (1) KR100510366B1 (xx)
CN (1) CN1114405C (xx)
AT (1) ATE232100T1 (xx)
AU (1) AU755882B2 (xx)
BG (1) BG65087B1 (xx)
BR (1) BR9814924B1 (xx)
CA (1) CA2319015C (xx)
CZ (1) CZ299192B6 (xx)
DE (1) DE69811278T3 (xx)
DK (1) DK1051174T4 (xx)
EA (1) EA002879B1 (xx)
EE (1) EE05620B1 (xx)
ES (1) ES2189232T5 (xx)
FR (1) FR2774288B1 (xx)
GE (1) GEP20032941B (xx)
HK (1) HK1032354A1 (xx)
HU (1) HU229956B1 (xx)
IL (1) IL137536A0 (xx)
IS (1) IS2866B (xx)
NO (1) NO330144B1 (xx)
NZ (1) NZ505998A (xx)
PL (1) PL200043B1 (xx)
PT (1) PT1051174E (xx)
RS (1) RS50245B (xx)
SI (1) SI1051174T2 (xx)
SK (1) SK285666B6 (xx)
TR (1) TR200002214T2 (xx)
UA (1) UA61988C2 (xx)
WO (1) WO1999038511A1 (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2790668B1 (fr) * 1999-03-12 2002-07-26 D B F Granules contenant une substance vegetale et leur procede de preparation
FR2793688B1 (fr) * 1999-05-21 2003-06-13 Ethypharm Lab Prod Ethiques Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques
FR2845289B1 (fr) * 2002-10-04 2004-12-03 Ethypharm Sa Spheroides, procede de preparation et compositions pharmaceutiques.
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
EP1603537A4 (en) * 2003-02-20 2009-11-04 Santarus Inc IMMEDIATE RELEASE OF OMEPRAZOLE ANTACIDAL COMPLEX WITH NEW FORMULATION FOR RAPID AND PROLONGED ELIMINATION OF GASTRIC ACID
ES2234393B2 (es) * 2003-04-29 2006-09-01 Laboratorios Belmac, S.A. "formulaciones de pelets de compuestos bencimidazolicos antiulcerosos y labiles al acido".
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
JP2006528181A (ja) * 2003-07-18 2006-12-14 サンタラス インコーポレイティッド 酸分泌を阻害するために有用な薬学的製剤ならびにそれらを作製および使用する方法
AU2004257864A1 (en) * 2003-07-18 2005-01-27 Santarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
JP5171038B2 (ja) * 2003-10-10 2013-03-27 エティファルム イチョウ・エキスを含む放出持続性の微小顆粒およびそのような顆粒の製造方法
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
JP2007522217A (ja) * 2004-02-10 2007-08-09 サンタラス インコーポレイティッド プロトンポンプ阻害剤、緩衝剤および非ステロイド系抗炎症薬の組み合わせ
CA2561700A1 (en) * 2004-04-16 2005-12-15 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and prokinetic agent
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
JP5563735B2 (ja) * 2004-06-16 2014-07-30 タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド Ｐｐｉ多回剤形
EP1965774A2 (en) * 2005-12-30 2008-09-10 Cogentus Pharmaceuticals, Inc. Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
WO2007115305A2 (en) 2006-04-04 2007-10-11 Cogentus Pharmaceuticals, Inc. Oral dosage forms including an antiplatelet agent and an acid inhibitor
EP2026768B1 (en) * 2006-06-01 2018-02-28 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
EP2081546A2 (en) * 2006-10-17 2009-07-29 Ranbaxy Laboratories Limited Multiple unit tablet compositions of benzimidazole compounds
CA2860231A1 (en) 2011-12-28 2013-07-04 Pozen Inc. Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
EP3117824A1 (en) 2015-07-17 2017-01-18 BE Pharbel Manufacturing Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form
AU2016294734B2 (en) 2015-07-17 2021-01-28 BE Pharbel Manufacturing Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form
WO2017145146A1 (en) 2016-02-25 2017-08-31 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
FR3078630B1 (fr) 2018-03-08 2021-05-14 Karim Ioualalen Mode de formulation sous forme de solide divise hydrophobe

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
JPH0768125B2 (ja) * 1988-05-18 1995-07-26 エーザイ株式会社 酸不安定化合物の内服用製剤
FR2692146B1 (fr) * 1992-06-16 1995-06-02 Ethypharm Sa Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
DE69527364T2 (de) * 1994-09-30 2003-03-13 Medical Security Corp., Portland Verfahren zum reinigen und rutschfesten behandlung von oberflächenbelägen
ES2094694B1 (es) † 1995-02-01 1997-12-16 Esteve Quimica Sa Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
CH687810A5 (de) 1995-05-24 1997-02-28 Mepha Ag Pelletformulierung mit Omeprazol.
DE69631981T2 (de) * 1995-09-21 2005-04-14 Pharma Pass Ii Llc, Irvine Lansoprazolhaltige Arzneizusammensetzung und Herstellungsverfahren
EP0941074B1 (en) * 1996-11-06 2004-07-21 Wockhardt Europe Limited Delayed delivery system for acid-sensitive drugs
GB9710800D0 (en) * 1997-05-23 1997-07-23 Cipla Limited Pharmaceutical composition and method of preparing it
SE9704870D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
SE9704869D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II

Also Published As

Publication number Publication date
YU48400A (sh) 2003-02-28
BR9814924A (pt) 2000-10-17
RS50245B (sr) 2009-07-15
KR20010040502A (ko) 2001-05-15
FR2774288B1 (fr) 2001-09-07
CZ299192B6 (cs) 2008-05-14
IL137536A0 (en) 2001-07-24
PL200043B1 (pl) 2008-11-28
UA61988C2 (uk) 2003-12-15
AU9074898A (en) 1999-08-16
HU229956B1 (hu) 2015-03-02
BG65087B1 (bg) 2007-02-28
EE200000466A (et) 2002-04-15
EE05620B1 (et) 2013-02-15
CA2319015A1 (fr) 1999-08-05
NO330144B1 (no) 2011-02-21
DE69811278T3 (de) 2012-11-29
BG104634A (bg) 2001-02-28
IS2866B (is) 2014-01-15
PL342044A1 (en) 2001-05-21
JP4286452B2 (ja) 2009-07-01
ES2189232T3 (es) 2003-07-01
CA2319015C (fr) 2008-08-05
SK11412000A3 (sk) 2001-04-09
ES2189232T5 (es) 2012-11-07
SI1051174T2 (sl) 2013-01-31
EP1051174B1 (fr) 2003-02-05
HUP0100347A3 (en) 2002-12-28
EP1051174B2 (fr) 2012-07-04
CN1284877A (zh) 2001-02-21
TR200002214T2 (tr) 2000-12-21
EA200000797A1 (ru) 2001-02-26
SK285666B6 (sk) 2007-05-03
PT1051174E (pt) 2003-06-30
WO1999038511A1 (fr) 1999-08-05
CN1114405C (zh) 2003-07-16
NZ505998A (en) 2003-11-28
FR2774288A1 (fr) 1999-08-06
CZ20002709A3 (cs) 2000-12-13
DK1051174T3 (da) 2003-05-26
BR9814924B1 (pt) 2010-07-13
EA002879B1 (ru) 2002-10-31
EP1051174A1 (fr) 2000-11-15
DK1051174T4 (da) 2012-10-01
NO20004654L (no) 2000-09-18
ATE232100T1 (de) 2003-02-15
KR100510366B1 (ko) 2005-08-24
GEP20032941B (en) 2003-04-25
IS5577A (is) 2000-07-25
US6551621B1 (en) 2003-04-22
NO20004654D0 (no) 2000-09-18
DE69811278D1 (de) 2003-03-13
HUP0100347A2 (hu) 2001-10-28
SI1051174T1 (en) 2003-06-30
AU755882B2 (en) 2003-01-02
JP2002501895A (ja) 2002-01-22
DE69811278T2 (de) 2003-11-27

Similar Documents

Publication Publication Date Title
HK1032354A1 (en) Gastroprotected omerprazole microgranules, method for obtaining same and pharmaceutical preparations
HK1018396A1 (en) Delivery system of an active agent.
PL327767A1 (en) Drugs containing known auxiliary substances and an active substance
HK1037974A1 (en) Pharmaceutical formulations for aerosols with two or more active substances.
ZA992549B (en) Incorporation of active substances in carrier matrixes.
AU2002223074A1 (en) Microgranules based on active principle and method for making same
AU6995700A (en) Therapeutic system containing an active substance for the application on the skin which contains at least two polymerous layers
DE69919490D1 (de) Puder mit fettlöslichem wirkstoff
HK1032010A1 (en) Medicament formulation with a controlled release of an active agent.
EP0960885A4 (en) DEPSIPEPTIDES AND MEDICATIONS, WHICH CONTAIN THE SAME AS ACTIVE INGREDIENCIES
HK1036402A1 (en) Morphine sulphate microgranules, method for makingsame and pharmaceutical preparations.
ATE187890T1 (de) Ligandgerichtete enzyme-prodrug therapie
HRP20020165B1 (en) Low-dose tablets and preparation method
WO1997026867A3 (de) Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung
ZA200007111B (en) Methods and devices for providing prolonged drug therapy.
EP0995758A4 (en) PHYSIOLOGICALLY ACTIVE POLYOXYPEPTINE AND DEOXYPOLYOXYPEPTINE AND CANCER DRUGS CONTAINING THEM
ZA977873B (en) Dosage form and method for administering drug.

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20180809